// App-Quantinova.ai

WP160 : A Post-Hoc Assessment of Current Hormone Therapy on Revascularization Risk in Women: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)

Researchers

Presenter

  • Ariane Mackey

Principal Investigators

  • Hopital de -Enfant-Jesus

  • Mary E Longbottom

  • Alice J Sheffet

  • Thomas G Brott

  • Helmi L Lutsep

  • Genevieve Milot

  • Jenifer H Voeks

  • Virginia J Howard

  • Susan E Hughes

  • Mee Lee Tom

Medical Centers

  • Mayo Clinic, Jacksonville, FL

  • Oregon Health and Science University, Portland, OR

  • Medcl Univ of South Carolina, Charleston, SC

  • University of Medicine and Dentistry of New Jersey - RWJMS, New Brunswick, NJ

  • University of Alabama at Birmingham, Birmingham, AL

  • CHUL, Quebec, QC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Dyslipidemia

  • Hypertension

  • Stroke

Biomarkers

  • Carcinoembryonic antigen

  • Cellular apoptosis susceptibility protein

Drug/Treatment

  • stannous fluoride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved